PHAT Phathom Pharmaceuticals, Inc.
$4.66
Phathom Pharmaceuticals, Inc. (PHAT) Earnings News
Earnings press releases, previews and reviews for Phathom Pharmaceuticals, Inc. (PHAT), newest first. Our most recent is review: Phathom Misses on a Decelerating Quarter as Cash-Flow Progress Collides With a New VOQUEZNA Exclusivity Overhang.
Thursday
October 29, 2026
11:08 AM ET
Phathom Misses on a Decelerating Quarter as Cash-Flow Progress Collides With a New VOQUEZNA Exclusivity Overhang
Earnings Whispers · Review
Thursday
October 29, 2026
7:00 AM ET
Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Wednesday
October 21, 2026
1:38 PM ET
Phathom's Prescribing Friction Faces Its First Test After Guidance Cut Rattled Investors
Earnings Whispers · Preview
Monday
October 19, 2026
8:00 AM ET
Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
Thursday
July 30, 2026
6:59 AM ET
Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Monday
July 20, 2026
8:00 AM ET
Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026